Page last updated: 2024-10-28

hydroxychloroquine and Eye Disorders

hydroxychloroquine has been researched along with Eye Disorders in 48 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"To investigate the usefulness of hydroxychloroquine (HCQ) dose-loading to increase the percentage of responders or rate of response in treating rheumatoid arthritis (RA)."9.09Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. ( Baethge, B; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Weisman, M; Welch, KE; Yocum, D, 1999)
"A dose-response relationship for hydroxychloroquine (HCQ), in terms of the proportion of patients achieving the Paulus 20% criteria for improvement, had previously been observed in patients with rheumatoid arthritis (RA) receiving a 6-week loading regimen of 400, 800, or 1,200 mg HCQ daily."7.71Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. ( Baethge, BA; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Gibbs, JP; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Munster, T; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Shen, D; Weisman, M; Welch, KE; Yocum, D, 2002)
"Hydroxychloroquine is a widely used medication for various clinical conditions mainly rheumatological and dermatological autoimmune diseases e."5.72Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report. ( Ameen Ismail, A; Hatata, RM; Sadek, SH, 2022)
"To investigate the usefulness of hydroxychloroquine (HCQ) dose-loading to increase the percentage of responders or rate of response in treating rheumatoid arthritis (RA)."5.09Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. ( Baethge, B; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Weisman, M; Welch, KE; Yocum, D, 1999)
"Hydroxychloroquine and quinacrine are frequently used to treat rheumatic diseases."5.01Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate? ( Samson, CM; Schwartzman, S, 2019)
"The antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been used for decades to treat rheumatic diseases."4.87Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature. ( Koren, G; Osadchy, A; Ratnapalan, T, 2011)
"A dose-response relationship for hydroxychloroquine (HCQ), in terms of the proportion of patients achieving the Paulus 20% criteria for improvement, had previously been observed in patients with rheumatoid arthritis (RA) receiving a 6-week loading regimen of 400, 800, or 1,200 mg HCQ daily."3.71Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. ( Baethge, BA; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Gibbs, JP; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Munster, T; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Shen, D; Weisman, M; Welch, KE; Yocum, D, 2002)
"The development of our RMA approach was motivated by a currently relevant clinical question: is ocular toxicity and vision compromise a side effect of hydroxychloroquine therapy? At the time of designing this study, hydroxychloroquine was a leading candidate in the treatment of coronavirus disease (COVID-19)."2.66Artificial Intelligence for Rapid Meta-Analysis: Case Study on Ocular Toxicity of Hydroxychloroquine. ( Chow, T; Martin, NA; Michelson, M; Minton, S; Ross, M; Tee Qiao Ying, A, 2020)
" A new study indicates that toxicity is not as rare as once believed, but depends critically on daily dosage and duration of use, as well as other risk factors."2.52A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye. ( Brézin, AP; Costedoat-Chalumeau, N; Dunogué, B; Jallouli, M; Le Guern, V; Leroux, G; Marmor, MF; Melles, RB; Morel, N; Piette, JC, 2015)
"Quinacrine does not cause retinopathy, but it has more cutaneous side effects than the other two agents."2.36Antimalarials. ( Koranda, FC, 1981)
"Hydroxychloroquine is a widely used medication for various clinical conditions mainly rheumatological and dermatological autoimmune diseases e."1.72Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report. ( Ameen Ismail, A; Hatata, RM; Sadek, SH, 2022)
" We revised the antimalarials use in Rheumatology, their utility, doses, adverse events and risk factors as cumulate doses, ideal daily doses, renal function and ophthalmological reviews recommendations."1.31[Eye toxicity of antimalarial agents]. ( Cabana Vázquez, M; Graña Gil, J; Sánchez Meizoso, MO; Vázquez González, A, 2002)
"Surgical treatment of cataracts, band keratopathy, and glaucoma achieved uniformly discouraging results."1.25Ocular manifestations of juvenile rheumatoid arthritis. ( Bellows, AR; Bienfang, DC; Chylack, LT; Stillman, JS, 1975)

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-199023 (47.92)18.7374
1990's3 (6.25)18.2507
2000's6 (12.50)29.6817
2010's8 (16.67)24.3611
2020's8 (16.67)2.80

Authors

AuthorsStudies
Jorge, AM1
Mancini, C1
Zhou, B1
Ho, G1
Zhang, Y1
Costenbader, K1
Choi, HK1
Ameen Ismail, A1
Sadek, SH1
Hatata, RM1
Kellner, U3
Kellner, S3
Weinitz, S3
Farmand, G3
Dias-Santos, A1
Tavares Ferreira, J1
Pinheiro, S1
Cunha, JP1
Alves, M1
Papoila, AL1
Moraes-Fontes, MF1
Proença, R1
Gegúndez-Fernández, JA1
Zarranz-Ventura, J1
Garay-Aramburu, G1
Muñoz-Negrete, FJ1
Mendicute Del Barrio, J1
Pablo-Júlvez, L1
García-Delpech, S1
López-Alemany, A1
Arnalich-Montiel, F1
Cordero-Coma, M1
Cárceles, JA1
Michelson, M1
Chow, T1
Martin, NA1
Ross, M1
Tee Qiao Ying, A1
Minton, S1
Carter, KL1
Do, DV1
Menet, J1
Agrinier, N1
Dufrost, V1
Conart, JB1
Wahl, D1
Duprez, KA1
Zuily, S1
Lin, TC1
Marmor, MF3
Barbhaiya, M1
Guan, H1
Chen, SK1
Feldman, CH1
Costenbader, KH1
Dammacco, R1
Procaccio, P1
Racanelli, V1
Vacca, A1
Dammacco, F1
Schwartzman, S1
Samson, CM1
Costedoat-Chalumeau, N1
Dunogué, B1
Leroux, G1
Morel, N1
Jallouli, M1
Le Guern, V1
Piette, JC1
Brézin, AP1
Melles, RB1
McCune, WJ1
Gonzalez-Rivera, T1
Kowalczyk, JP1
Ricotti, CA1
de Araujo, T1
Drosou, A1
Nousari, CH1
Heravian, J1
Saghafi, M1
Shoeibi, N1
Hassanzadeh, S1
Shakeri, MT1
Sharepoor, M1
Osadchy, A1
Ratnapalan, T1
Koren, G1
Munster, T1
Gibbs, JP1
Shen, D1
Baethge, BA1
Botstein, GR2
Caldwell, J2
Dietz, F2
Ettlinger, R2
Golden, HE2
Lindsley, H2
McLaughlin, GE2
Moreland, LW2
Roberts, WN2
Rooney, TW2
Rothschild, B2
Sack, M2
Sebba, AI2
Weisman, M2
Welch, KE2
Yocum, D2
Furst, DE2
KERSLEY, GD1
Samanta, A1
Goh, L1
Bawendi, A1
Mavrikakis, I1
Mavrikakis, E1
Shearer, RV1
Dubois, EL1
Koranda, FC1
Tanenbaum, L1
Tuffanelli, DL1
Baethge, B1
Jones, SK1
Fielder, A1
Graham, E1
Jones, S1
Silman, A1
Tullo, A1
Motta, M1
Tincani, A1
Faden, D1
Zinzini, E1
Chirico, G1
Graña Gil, J1
Cabana Vázquez, M1
Vázquez González, A1
Sánchez Meizoso, MO1
Klein, SA1
Tomaro, AJ1
Chylack, LT1
Bienfang, DC1
Bellows, AR1
Stillman, JS1
Maksymowych, W1
Russell, AS1
Sammartino, JP1
Soll, DB1
Sugar, J1
Henkind, P2
Gold, DH1
Laaksonen, AL1
Koskiahde, V1
Juva, K1
Nylander, U1
David-Chaussé, J1
David-Chaussé, F1
Picot, C1
Laporte, G1
Lagoarde, J1
Dehais, J1
Crews, SJ1
Alfieri, R1
Sole, P1
Sassaman, FW1
Cassidy, JT1
Alpern, M1
Maaseidvaag, F1
Zvaifler, NJ1
Sarmela, T1
Kajander, A1
Bertrand, JJ2
Debeyre, N1
Kahn, MF1
Ryckewaert, A1
Carr, RE1
Rothfield, N1
Siegel, IM1
Chiari, JJ1
Freyberg, RH1
Arden, GB1
Kolb, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss ,Double Blinded Randomized Controlled Trial .[NCT05237843]Phase 170 participants (Anticipated)Interventional2022-03-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for hydroxychloroquine and Eye Disorders

ArticleYear
Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
    Archivos de la Sociedad Espanola de Oftalmologia, 2020, Volume: 95, Issue:6

    Topics: Antimalarials; Asymptomatic Diseases; Betacoronavirus; Blood Safety; Chloroquine; Contact Lenses; Co

2020
Artificial Intelligence for Rapid Meta-Analysis: Case Study on Ocular Toxicity of Hydroxychloroquine.
    Journal of medical Internet research, 2020, 08-17, Volume: 22, Issue:8

    Topics: Artificial Intelligence; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Eye; Eye Disease

2020
Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
    Rheumatic diseases clinics of North America, 2019, Volume: 45, Issue:3

    Topics: Antimalarials; Chloroquine; Eye Diseases; Humans; Hydroxychloroquine; Patient Care Management; Rheum

2019
A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Clinical reviews in allergy & immunology, 2015, Volume: 49, Issue:3

    Topics: Animals; Chloroquine; Drug Dosage Calculations; Eye Diseases; Humans; Hydroxychloroquine; Lupus Eryt

2015
Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.
    The Journal of rheumatology, 2011, Volume: 38, Issue:12

    Topics: Antimalarials; Child; Chloroquine; Databases, Factual; Eye; Eye Diseases; Female; Humans; Hydroxychl

2011
Antimalarials.
    Journal of the American Academy of Dermatology, 1981, Volume: 4, Issue:6

    Topics: Antimalarials; Chloroquine; DNA; Eye Diseases; Humans; Hydroxychloroquine; Quinacrine; RNA; Skin Dis

1981
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
    Archives of dermatology, 1980, Volume: 116, Issue:5

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hemat

1980
Ocular toxicity and hydroxychloroquine: guidelines for screening.
    The British journal of dermatology, 1999, Volume: 140, Issue:1

    Topics: Antimalarials; Eye Diseases; Humans; Hydroxychloroquine; Mass Screening; Practice Guidelines as Topi

1999
Antimalarials in rheumatology: efficacy and safety.
    Seminars in arthritis and rheumatism, 1987, Volume: 16, Issue:3

    Topics: Antimalarials; Arthritis, Rheumatoid; Biomechanical Phenomena; Chloroquine; Clinical Trials as Topic

1987
Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
    Rheumatology, 1973, Volume: 4, Issue:0

    Topics: Adrenal Cortex Hormones; Arteritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Chloroquine; Conjunc

1973

Trials

5 trials available for hydroxychloroquine and Eye Disorders

ArticleYear
A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.
    International ophthalmology, 2011, Volume: 31, Issue:4

    Topics: Adult; Antirheumatic Agents; Color Vision; Early Diagnosis; Evoked Potentials, Visual; Eye Diseases;

2011
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Arthritis and rheumatism, 1999, Volume: 42, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response

1999
Antimalarials in rheumatology: efficacy and safety.
    Seminars in arthritis and rheumatism, 1987, Volume: 16, Issue:3

    Topics: Antimalarials; Arthritis, Rheumatoid; Biomechanical Phenomena; Chloroquine; Clinical Trials as Topic

1987
Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Scandinavian journal of rheumatology, 1974, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Arthritis, Juvenile; Child; Child, Preschool; Chloroquine; Clinical Trials as Top

1974
The prevention of drug-induced retinopathies.
    Transactions of the ophthalmological societies of the United Kingdom, 1966, Volume: 86

    Topics: Adolescent; Adult; Aged; Chloroquine; Clinical Trials as Topic; Eye; Eye Diseases; Female; Humans; H

1966

Other Studies

34 other studies available for hydroxychloroquine and Eye Disorders

ArticleYear
Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.
    JAMA, 2022, 10-11, Volume: 328, Issue:14

    Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Eye Diseases; Humans; Hydroxychloroquine; Lu

2022
Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
    BMC ophthalmology, 2022, Nov-14, Volume: 22, Issue:1

    Topics: Adult; Antirheumatic Agents; Eye Diseases; Female; Humans; Hydroxychloroquine; Lupus Erythematosus,

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
[Exogenously induced retinopathies].
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:12

    Topics: Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Humans; Hydroxychloroquine; Pentosan

2022
Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center.
    Lupus, 2020, Volume: 29, Issue:3

    Topics: Adult; Antirheumatic Agents; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Female;

2020
Drs. Carter and Do reply.
    The Journal of rheumatology, 2021, 01-01, Volume: 48, Issue:1

    Topics: Eye Diseases; Humans; Hydroxychloroquine

2021
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
    Lupus, 2021, Volume: 30, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Eye Disease

2021
Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.
    Arthritis care & research, 2018, Volume: 70, Issue:11

    Topics: Adult; Antirheumatic Agents; Cohort Studies; Eye Diseases; Female; Humans; Hydroxychloroquine; Lupus

2018
Hydroxychloroquine During Cancer Therapy.
    Retinal cases & brief reports, 2019,Spring, Volume: 13, Issue:2

    Topics: Breast Neoplasms; Drug Therapy, Combination; Eye Diseases; Humans; Hydroxychloroquine

2019
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Drug-Related Side Effects and Adverse Reactions; Eye

2018
Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
    Current opinion in rheumatology, 2015, Volume: 27, Issue:3

    Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Diseases; Follow-Up

2015
"Strawberry gums" in sarcoidosis.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:5 Suppl

    Topics: Adult; Antibodies, Monoclonal; Eye Diseases; Female; Gingival Hyperplasia; Humans; Hydroxychloroquin

2008
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:6

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Eye Diseases; Gastrointestinal Dise

2002
THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Corneal Opacity; Electroretinography;

1964
Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance.
    Rheumatology (Oxford, England), 2004, Volume: 43, Issue:3

    Topics: Antirheumatic Agents; Evidence-Based Medicine; Eye Diseases; Guideline Adherence; Humans; Hydroxychl

2004
Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance. Comment on the article by Samanta et al.
    Rheumatology (Oxford, England), 2004, Volume: 43, Issue:8

    Topics: Antirheumatic Agents; Eye Diseases; Guideline Adherence; Humans; Hydroxychloroquine; Practice Guidel

2004
Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy.
    American journal of ophthalmology, 1967, Volume: 64, Issue:2

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Child; Cornea; Eye Diseases; Female; Fluoresceins; H

1967
Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine.
    Eye (London, England), 1998, Volume: 12 ( Pt 6)

    Topics: Antirheumatic Agents; Dermatologic Agents; Drug Administration Schedule; Eye Diseases; Humans; Hydro

1998
Antimalarial agents in pregnancy.
    Lancet (London, England), 2002, Feb-09, Volume: 359, Issue:9305

    Topics: Antimalarials; Eye Diseases; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Infant, Newborn;

2002
[Eye toxicity of antimalarial agents].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:4

    Topics: Adult; Antimalarials; Chloroquine; Eye Diseases; Female; Humans; Hydroxychloroquine; Lupus Erythemat

2002
Lupus erythematosus profundus: review of the literature and report of case.
    Journal of oral surgery (American Dental Association : 1965), 1975, Volume: 33, Issue:6

    Topics: Adult; Biopsy; Eye Diseases; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid

1975
Ocular manifestations of juvenile rheumatoid arthritis.
    American journal of ophthalmology, 1975, Volume: 79, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Juvenile; Atropine; Cataract; Ch

1975
Ocular toxicity of systemic drugs.
    American family physician, 1985, Volume: 31, Issue:1

    Topics: Adrenal Cortex Hormones; Antitubercular Agents; Chloroquine; Contraceptives, Oral; Digitalis; Eye Di

1985
Ocular side effects of systemic therapy of cutaneous diseases.
    International ophthalmology clinics, 1985,Spring, Volume: 25, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antimetabolites; Chloroquine; Eye Diseases; Humans;

1985
Ocular damage in chloroquine therapy.
    Acta ophthalmologica, 1967

    Topics: Adult; Arthritis, Rheumatoid; Child; Chloroquine; Color Perception Tests; Color Vision Defects; Corn

1967
[Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis].
    Revue du rhumatisme et des maladies osteo-articulaires, 1971, Volume: 38, Issue:11

    Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Aspirin; Chloroquine; Eye Diseases; Female; Follow-Up St

1971
On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1969, Volume: 158 Suppl

    Topics: Adult; Aged; Antimalarials; Chloroquine; Diagnosis, Differential; Electroretinography; Eye Diseases;

1969
Electroretinography in patients with connective tissue diseases treated with hydroxychloroquine.
    American journal of ophthalmology, 1970, Volume: 70, Issue:4

    Topics: Arthritis, Rheumatoid; Color Perception Tests; Electroretinography; Eye Diseases; Eye Movements; Hum

1970
Antimalarial treatment of rheumatoid arthritis.
    The Medical clinics of North America, 1968, Volume: 52, Issue:3

    Topics: Antimalarials; Arthritis, Rheumatoid; Chloroquine; Eye Diseases; Humans; Hydroxychloroquine; Retina

1968
[Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
    Duodecim; laaketieteellinen aikakauskirja, 1968, Volume: 84, Issue:5

    Topics: Arthritis, Rheumatoid; Chloroquine; Cornea; Eye Diseases; Female; Humans; Hydroxychloroquine; Male

1968
[Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    La Presse medicale, 1968, Nov-23, Volume: 76, Issue:45

    Topics: Antimalarials; Chloroquine; Corneal Opacity; Drug Tolerance; Electroretinography; Eye Diseases; Hydr

1968
Ocular toxicity of antimalarial drugs. Long-term follow-up.
    American journal of ophthalmology, 1968, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Electrooculography; Electror

1968
[Transitory retinopathy caused by prolonged treatment with hydroxychloroquine sulfate].
    Archivos medicos panamenos, 1965, Volume: 14, Issue:1

    Topics: Antimalarials; Arthritis, Rheumatoid; Eye Diseases; Female; Humans; Hydroxychloroquine; Lupus Erythe

1965
Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.
    British medical journal, 1966, Jan-29, Volume: 1, Issue:5482

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Chloroquine; Electrooculography; Eye Diseases; Femal

1966
[Electroretinography in 83 patients treated with synthetic antimalarials].
    Bulletin des societes d'ophtalmologie de France, 1966, Volume: 66, Issue:10

    Topics: Adolescent; Adult; Aged; Antimalarials; Child; Chloroquine; Electroretinography; Eye Diseases; Femal

1966
chemdatabank.com